APA (7th ed.) Citation

Zongyu Li, Zongyu Li, Shangwen Guo, Shangwen Guo, Haoyi Xue, Luying Li, . . . He Zhu. (2023). Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: A single-arm meta-analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Zongyu Li, Zongyu Li, Shangwen Guo, Shangwen Guo, Haoyi Xue, Luying Li, Yuyuan Guo, Sinuo Duan, and He Zhu. Efficacy and Safety of Trastuzumab Deruxtecan in the Treatment of HER2-low/positive Advanced Breast Cancer: A Single-arm Meta-analysis. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Zongyu Li, et al. Efficacy and Safety of Trastuzumab Deruxtecan in the Treatment of HER2-low/positive Advanced Breast Cancer: A Single-arm Meta-analysis. Frontiers Media S.A., 2023.